Skip to main content
. 2020 Sep 1;10(9):2993–3036.

Figure 6.

Figure 6

Mechanism of potential anti-HCC targets in multiple signaling pathways. TM4SF1 (transmembrane 4 L6 family member 1), NVP-TNKS656 (a TNKS inhibitor), Axin (scaffold protein), GSK3β (glycogen synthase kinase 3 beta), APC (adenomatous polyposis coli), DKK1 (dickkopf-related protein 1), p38γ (p38 MAPK gamma), NOD1 (nucleotide-binding oligomerization 1), UBE2Z (ubiquitin conjugating enzyme E2Z), TMUB1 (transmembrane and ubiquitin-like domain-containing 1 protein), TNFAIP1 (tumor necrosis factor a-induced protein 1), IGFBP2 (insulin-like growth factor-binding protein 2), MSI2 (Musashi2).